Motor System Activation With Transcranial Direct Current Stimulation and Physical Exercise to Reduce Pain in Elderly
NCT ID: NCT04332939
Last Updated: 2023-03-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
32 participants
INTERVENTIONAL
2020-12-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of the Efficacy of Transcranial Direct Current Stimulation (tDCS) of the Primary Motor Cortex (M1) or the Prefrontal Cortex Combined With Aerobic Activity for Alleviation of Fibromyalgia Symptoms.
NCT06263972
The Effects of Transcranial Direct Current Stimulation Combined With Resistance Training on Motor Learning in Healthy Young Adults
NCT07092098
Neuromodulation of Cognition in Older Adults
NCT02137122
Modulating Brain Activity to Improve Goal-directed Physical Activity in Older Adults
NCT04278560
Advancing Alzheimer's Care: Home-based tDCS for Affective Symptoms
NCT06801639
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Elderly suffering from chronic pain will be recruited in this double-blind, parallel-group, randomised control trial. Participants will be randomized to receive exercises combined to real tDCS (5 daily sessions, 2 mA, 20 minutes) or to sham tDCS. Intervention will last 8 weeks at a rate of 3 workouts per week.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise + real tDCS
Intervention will last 8 weeks where participants will be trained at a rate of 3 workouts per week.
For the first week, participants will receive 5 daily sessions of anodal tDCS (2 mA, 20 min).
transcranial direct current stimulation
real tDCS sessions
Physical exercise
Aerobic exercise and physical training combined with sham tDCS
Exercise + Sham tDCS
Intervention will last 8 weeks where participants will be trained at a rate of 3 workouts per week.
For the first week, participants will receive 5 daily sessions of sham tDCS.
Physical exercise
Aerobic exercise and physical training combined with sham tDCS
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
transcranial direct current stimulation
real tDCS sessions
Physical exercise
Aerobic exercise and physical training combined with sham tDCS
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Not to change medication and life habits during the study
Exclusion Criteria
* To have an uncontrolled cardiovascular disease
* To have orthopedic limitation or contraindication to physical exercise
* To have contraindication to tDCS
* To have contraindication to TMS
* To have contraindication to MRI
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Université de Sherbrooke
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Guillaume Léonard
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guillaume Léonard, pht, PhD.
Role: PRINCIPAL_INVESTIGATOR
Université de Sherbrooke
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Centre on Aging
Sherbrooke, Quebec, Canada
Grace Village
Sherbrooke, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Guillaume Léonard, pht, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-3273
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.